Journal article icon

Journal article

'Luteal Analgesia’: Progesterone decreases pain unpleasantness by influencing emotion regulation networks

Abstract:

Background

Pregnancy-induced analgesia is known to occur in association with the very high levels of estradiol and progesterone circulating during pregnancy. In women with natural ovulatory menstrual cycles, more modest rises in these hormones occur on a monthly basis. We therefore hypothesised that the high estradiol high progesterone state indicative of ovulation would be associated with a reduction in the pain experience.

Methods

We used fMRI and a noxious thermal stimulus to explore the relationship between sex steroid hormones and the pain experience. Specifically, we assessed the relationship with stimulus-related activity in key regions of networks involved in emotion regulation, and functional connectivity between these regions.

Results

We demonstrate that physiologically high progesterone levels are associated with a reduction in the affective component of the pain experience and a dissociation between pain intensity and unpleasantness. This dissociation is related to decreased functional connectivity between the inferior frontal gyrus and amygdala. Moreover, we have shown that in the pre-ovulatory state, the traditionally “male” sex hormone, testosterone, is the strongest hormonal regulator of pain-related activity and connectivity within the emotional regulation network. However, following ovulation the traditionally “female” sex hormones, estradiol and progesterone, appear to dominate.

Conclusions

We propose that a phenomenon of ‘luteal analgesia’ exists with potential reproductive advantages.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Womens & Reproductive Health
Department:
Oxford, MSD, Womens & Reproductive Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Womens & Reproductive Health
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Womens & Reproductive Health
Role:
Author


Publisher:
Frontiers Media
Journal:
Frontiers in Endocrinology More from this journal
Volume:
9
Pages:
413
Publication date:
2018-07-23
Acceptance date:
2018-07-02
DOI:
EISSN:
1664-2392


Keywords:
Pubs id:
pubs:860138
UUID:
uuid:71f09b2c-54b1-4a47-b515-475a2c484d9a
Local pid:
pubs:860138
Deposit date:
2018-07-02
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP